Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Holmberg

Showing results (411-420 of 509) with videos related to

Pageof 51
Sort By:
Bone Marrow Transplantation|October 25, 2016
Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomasJ Gauthier, L Holmberg, D Wu, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2006
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trialA Ringberg, H Nordgren, S Thorstensson, et al.
Thrombosis Research|March 25, 2011
Prolonged half-life of glycoPEGylated rFVIIa variants compared to native rFVIIaDitte M Karpf, Brit B Sørensen, Mette B Hermit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
The British Journal of Surgery|August 29, 2003
Risk factors for local recurrence after breast-conserving surgeryI Fredriksson, G Liljegren, M Palm-Sjövall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Blood|July 27, 2001
Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosisJ E Anderson, A Tefferi, F Craig, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2014
Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationshipA Purushotham, E Shamil, M Cariati, et al.
Bone Marrow Transplantation|July 23, 1998
Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex systemS D Rowley, M Loken, J Radich, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2003
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screeningP Malmström, L Holmberg, H Anderson, et al.
Pageof 51

Showing results (411-420 of 509) with videos related to

Sort By:
Pageof 51
Bone Marrow Transplantation|October 25, 2016
Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomasJ Gauthier, L Holmberg, D Wu, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2006
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trialA Ringberg, H Nordgren, S Thorstensson, et al.
Thrombosis Research|March 25, 2011
Prolonged half-life of glycoPEGylated rFVIIa variants compared to native rFVIIaDitte M Karpf, Brit B Sørensen, Mette B Hermit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
The British Journal of Surgery|August 29, 2003
Risk factors for local recurrence after breast-conserving surgeryI Fredriksson, G Liljegren, M Palm-Sjövall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Blood|July 27, 2001
Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosisJ E Anderson, A Tefferi, F Craig, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2014
Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationshipA Purushotham, E Shamil, M Cariati, et al.
Bone Marrow Transplantation|July 23, 1998
Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex systemS D Rowley, M Loken, J Radich, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2003
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screeningP Malmström, L Holmberg, H Anderson, et al.
Pageof 51